Cirrhotic Cardiomyopathy After Transplantation: Neither the Transient Nor Innocent Bystander

Cirrhotic cardiomyopathy in end‐stage liver disease is currently characterized by blunted contractile systolic response to stress with or without diastolic dysfunction in the absence of known heart disease. Since the establishment of the diagnostic criteria of cirrhotic cardiomyopathy in 2005, there have been multiple studies regarding its pathophysiology and pretransplant clinical course. The data regarding the post‐transplant course of this entity are sparse. This review addresses the course and prognosis of the elements of cirrhotic cardiomyopathy after liver transplantation (LT). To this end, there is limited compelling evidence demonstrating the reversibility of this entity post‐LT. Cirrhotic cardiomyopathy may, in fact, increase the risk of post‐transplant complications. This review reveals a need to refine the diagnostic criteria of cirrhotic cardiomyopathy in view of the remarkable progress in the sphere of echocardiographic evaluation of systolic and diastolic dysfunction. The post‐transplant course and outcomes related to cirrhotic cardiomyopathy may be better evaluated in the setting of updated diagnostic criteria.

• Publication year

  2018

• Venue

  Hepatology

• Publication date

  2018-10-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/hep.30040PMID 29672903
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cirrhotic cardiomyopathy

  2019cited by this paper
• Cirrhotic cardiomyopathy: Implications for liver transplantation

  2017cited by this paper
• Effect of

  2017cited by this paper
• Impact and persistence of cirrhotic cardiomyopathy after liver transplantation

  2016influential reference
• A detailed evaluation of cardiac function in cirrhotic patients and its alteration with or without liver transplantation.

  2016influential reference
• Factors Associated With Major Adverse Cardiovascular Events After Liver Transplantation Among a National Sample

  2016cited by this paper
• Cirrhotic cardiomyopathy in the pre- and post-liver transplantation phase.

  2016cited by this paper
• Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

  2016cited by this paper
• Preexisting atrial fibrillation and cardiac complications after liver transplantation

  2015cited by this paper
• Pre-transplant Left Ventricular Diastolic Dysfunction Is Associated with Post Transplant Acute Graft Rejection and Graft Failure

  2014influential reference
• Prognostic implications of global LV dysfunction: a systematic review and meta-analysis of global longitudinal strain and ejection fraction

  2014cited by this paper
• Diastolic stress echocardiography: the time has come for its integration into clinical practice.

  2014cited by this paper
• QT Interval Prolongation in End‐Stage Liver Disease Cannot Be Explained by Nonhepatic Factors

  2014cited by this paper
• LEFT VENTRICULAR SYSTOLIC STRAIN PREDICTS SUBSEQUENT HEART FAILURE: A COMMUNITY STUDY

  2013cited by this paper
• The Relationship between QT Interval Dispersion and End-Stage Liver Disease Score in the Patients Undergoing Orthotopic Liver Transplantation

  2013cited by this paper
• Diastolic Dysfunction in Patients With End-Stage Liver Disease is Associated With Development of Heart Failure Early After Liver Transplantation

  2012influential reference
• Diastolic Dysfunction and Risk of Atrial Fibrillation: A Mechanistic Appraisal

  2012cited by this paper
• Diastolic dysfunction in patients with end-stage liver disease is associated with development of heart failure early after liver transplantation.

  2011cited by this paper
• Cirrhotic cardiomyopathy.

  2010cited by this paper
• Cirrhotic cardiomyopathy.

  2010cited by this paper
• Alterations in Corrected QT Interval Following Liver Transplant in Patients With End‐Stage Liver Disease

  2010cited by this paper
• Cardiovascular complications of cirrhosis.

  2009cited by this paper
• Recommendations for the evaluation of left ventricular diastolic function by echocardiography.

  2008influential reference
• The effect of liver transplantation on autonomic dysfunction in patients with end‐stage liver disease

  2008cited by this paper
• Cardiovascular complications of cirrhosis

  2008cited by this paper
• Cirrhotic cardiomyopathy

  2007cited by this paper
• Effects of Orthotopic Liver Transplantation on the Corrected QT Interval in Patients with End-Stage Liver Disease

  2005cited by this paper
• Cardiac alterations in cirrhosis: reversibility after liver transplantation.

  2005influential reference
• Effect of cirrhosis and liver transplantation on the gender difference in QT interval.

  2005cited by this paper
• Prolongation of QTc interval: relationship with etiology and severity of liver disease, mortality and liver transplantation

  2003cited by this paper
• Ablation of haemodynamically unstable right ventricular outflow tract ventricular tachycardia guided by non-contact mapping

  2002cited by this paper
• Cardiac function after orthotopic liver transplantation and the effects of immunosuppression: A prospective randomized trial comparing cyclosporin (Neoral) and tacrolimus

  2002cited by this paper
• Reversal of QT interval electrocardiographic alterations in cirrhotic patients undergoing liver transplantation.

  1999cited by this paper
• Evaluation of cardiac function before and after liver transplantation.

  1999cited by this paper
• Effect of liver transplantation on QT interval prolongation and autonomic dysfunction in end‐stage liver disease

  1996cited by this paper
• Determination of parameters of left ventricular diastolic filling with pulsed Doppler echocardiography: comparison with cineangiography.

  1985cited by this paper

• Blunted Cardiac Reserve as a Marker of Cirrhotic Cardiomyopathy - Cardiac Outcomes Following Liver Transplantation and Comparison to the Existing Guidelines.

  2025cites this paper
• EASL postgraduate course report: Vascular biology in chronic liver disease and clinical management implications

  2025cites this paper
• Cirrhotic cardiomyopathy as a problem in liver transplantation

  2025cites this paper
• Severity of liver disease is associated with cirrhotic cardiomyopathy: A multicenter study.

  2025cites this paper
• CardioHepatology: Exploring the Interplay Between Cirrhosis, Cirrhotic Cardiomyopathy, Coronary Artery Disease, and Liver Transplantation.

  2025cites this paper
• ILTS/LICAGE Guidelines for Cardiovascular Assessment Before Liver Transplantation.

  2025cites this paper
• Cardiac dysfunction in patients with cirrhosis and acute decompensation

  2024cites this paper
• Cardiovascular disease assessment and management in liver transplantation.

  2024cites this paper
• H2FPEF Scores Are Increased in Patients with NASH Cirrhosis and Are Associated with Post-liver Transplant Heart Failure

  2024cites this paper
• Pediatric cirrhotic cardiomyopathy: literature review and effect size estimations of selected parameters

  2024influential citation
• Post-Transjugular Intrahepatic Portosystemic Shunt Right Atrial Pressure and Left Atrial Volume Index Predict Heart Failure and Mortality: Dual Center Experience.

  2024cites this paper
• The clinical relevance of the new criteria for cirrhotic cardiomyopathy and future directions

  2024cites this paper
• The mechanism of ferroptosis and its related diseases

  2023cites this paper
• Cirrhotic cardiomyopathy: Pathogenesis, clinical features, diagnosis, treatment and prognosis.

  2023cites this paper
• Evaluation of recipients with significant comorbidity - Patients with cardiovascular disease.

  2023cites this paper
• Cirrhotic cardiomyopathy – negative prognosis factor in cirrhosis

  2023cites this paper
• Subclinical cardiac abnormalities in children with biliary atresia correlate with outcomes after liver transplantation

  2023cites this paper
• The predictive value of revised diastolic dysfunction in outcomes of liver transplantation: A propensity score matching analysis

  2023cites this paper
• How non-alcoholic fatty liver disease and cirrhosis affect the heart

  2023cites this paper
• Cirrhotic cardiomyopathy: Appraisal of the original and revised criteria in predicting posttransplant cardiac outcomes

  2022cites this paper
• Features of Cirrhotic Cardiomyopathy Early in the Lives of Infants With Biliary Atresia Correlate With Outcomes Following Kasai Portoenterostomy

  2022cites this paper
• Analyzing the Different Prevalence for Cirrhotic Cardiomyopathy in Different Studies

  2022cites this paper
• Impact of Cirrhotic Cardiomyopathy Diagnosed According to Different Criteria on Patients with Cirrhosis Awaiting Liver Transplantation: A Retrospective Cohort Study

  2022cites this paper
• Zirrhotische Kardiomyopathie

  2021cites this paper
• Cardiac and Pulmonary Vascular Risk Stratification in Liver Transplantation.

  2021influential citation
• Relationship between QT interval prolongation and structural abnormalities in cirrhotic cardiomyopathy: A change in the current paradigm

  2021cites this paper
• Cirrhotic Cardiomyopathy Predicts Posttransplant Cardiovascular Disease: Revelations of the New Diagnostic Criteria

  2021cites this paper
• Cirrhotic Cardiomyopathy: An Evolving Diagnostic Entity With Long‐Term Clinical Sequelae

  2021cites this paper
• Reply To Letter To The Editor.

  2021cites this paper
• Current Concepts of Cirrhotic Cardiomyopathy.

  2021cites this paper
• Cardiovascular involvement after liver transplantation: role of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis

  2021influential citation
• Reply

  2021cites this paper
• Diagnosis and Management of Cirrhotic Cardiomyopathy.

  2021cites this paper
• What’s New in Cirrhotic Cardiomyopathy?—Review Article

  2021cites this paper
• Development of the AI-Cirrhosis-ECG Score: An Electrocardiogram-Based Deep Learning Model in Cirrhosis

  2021cites this paper
• Cirrhotic Cardiomyopathy

  2020cites this paper
• Cirrhotic Cardiomyopathy in the Era of Liver Transplantation: Time for Precise Stepwise Evaluation.

  2020cites this paper
• Sudden cardiac death following liver transplantation: Incidence, trends and risk predictors.

  2020cites this paper
• Cirrhotic Cardiomyopathy—A Veiled Threat

  2020cites this paper
• Effect of liver transplantation on QT-interval prolongation and impact on mortality.

  2020cites this paper
• Analogies and differences between cirrhotic cardiomyopathy and hepatopulmonary syndrome

  2020cites this paper
• Cardiovascular and metabolic disease in the liver transplant recipient.

  2020cites this paper
• Pharmacological management of portal hypertension and its complications in children: lessons from adults and opportunities for the future

  2020cites this paper
• Interplay of cardiovascular mediators, oxidative stress and inflammation in liver disease and its complications

  2020cites this paper
• Acute heart failure after liver transplantation: A narrative review

  2020cites this paper
• Markedly prolonged QTc interval in end‐stage liver disease and risk of 30‐day cardiovascular event after liver transplant

  2020cites this paper
• Physiopathological and diagnostic aspects of cirrhotic cardiomyopathy.

  2020cites this paper
• Pathogenesis of non-alcoholic fatty liver disease and implications on cardiovascular outcomes in liver transplantation.

  2020cites this paper
• Interplay of Liver–Heart Inflammatory Axis and Cannabinoid 2 Receptor Signaling in an Experimental Model of Hepatic Cardiomyopathy

  2020cites this paper
• Appraisal of Cardiac Ejection Fraction With Liver Disease Severity: Implication in Post–Liver Transplantation Mortality

  2020cites this paper
• Redefining Cirrhotic Cardiomyopathy for the Modern Era

  2020cites this paper
• Clinical Consequences of Cardiomyopathy in Children With Biliary Atresia Requiring Liver Transplantation

  2019cites this paper
• Understanding and managing cardiovascular outcomes in liver transplant recipients

  2019cites this paper
• Cardiac Imaging in Liver Transplantation Candidates: Current Knowledge and Future Perspectives

  2019influential citation
• Sarcopenia in Cirrhosis: Looking Beyond the Skeletal Muscle Loss to See the Systemic Disease

  2019influential citation
• World Journal of Hepatology

  year unknowncites this paper